Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: Implications for HCV therapy in HCV/HIV-coinfected patients

Journal of Infection

Volumn 54, Issue 2, 2007, Pages 173-179

  Ramos, Belén ^a   Núñez, Marina ^a   Toro, Carlos ^a   Sheldon, Julie ^a   García Samaniego, Javier ^a   Ríos, Pilar ^a   Soriano, Vincent ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Genotype; HCV; HIV; Interferon; Liver

Indexed keywords

INTERFERON;

ARTICLE; CLINICAL LABORATORY; DRUG SENSITIVITY; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; NONHUMAN; POPULATION DISTRIBUTION; PREVALENCE; RETROSPECTIVE STUDY; SEROTYPE; SPAIN; SUPERINFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV SEROPOSITIVITY; HUMANS; INTERFERONS; MALE; MIDDLE AGED; PREVALENCE; SPAIN;

EID: 33846141462     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2006.02.006     Document Type: Article

References (35)

1. National Institutes of Health Consensus Statement on Management of Hepatitis C: Gastroenterology vol. 123 (2002) pp. 2082-99
2. Simmonds P., Holmes E.C., Cha T.A., Chan S.W., McOmish F., Irvine B., et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74 (1993) 2391-2399
3. Hadziyannis S., and Koskinas J. Differences in epidemiology, liver disease and treatment response among HCV genotypes. Hepatol Res 29 (2004) 129-135
4. Hnatyszyn H. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir Ther 10 (2005) 1-11
5. Núñez M., and Soriano V. Hepatitis C virus (HCV) genotypes and disease progression in HIV/HCV-coinfected patients. J Infect Dis 191 (2005) 1-3
6. Soriano V., Núñez M., Sanchez-Conde M., Barreiro P., Garcia-Samaniego J., Martin-Carbonero L., et al. Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4. Antivir Ther 10 (2005) 167-170
7. Lauer G., and Walker B. Hepatitis C virus infection. N Engl J Med 345 (2001) 41-52
8. Rubio M., Rubio C., Nogues A., and Manonelles A. HCV genotypes: a study of 302 HIV/HCV-coinfected patients. Med Clin (Barc) 116 (2001) 650-651
9. Pawlotsky J.M. HCV genetic variability: pathogenic and clinical implications. Clin Liver Dis 7 (2003) 45-66
10. Van Asten L., Verhaest I., Lamzira S., Hernandez-Aguado I., Zangerle R., Boufassa F., et al. Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. J Infect Dis 189 (2004) 292-302
11. Stuyver L., Wyseur A., Van Arnhem W., Hernandez F., and Maertens G. Second-generation line probe assay for hepatitis C virus genotyping. J Clin Microbiol 34 (1996) 2259-2266
12. Touceda S., Pereira M., and Agulla A. Prevalence of hepatitis C virus genotypes in the area of El Ferrol (La Coruña, Spain). Enferm Infecc Microbiol Clin 20 (2002) 200-204
13. Pena M.J., Mosquera M.M., Pérez M.C., Rodríguez-San Roman J.L., Martin J.M., Avalos O., et al. Prevalence of hepatitis C virus genotypes: epidemiology and histologic characteristics. Enferm Infecc Microbiol Clin 16 (1998) 456-460
14. Watson J.P., Brind A.M., Chapman C.E., Bates C.L., Gould F.K., Johnson S.J., et al. Hepatitis C virus: epidemiology and genotypes in the north east of England. Gut 38 (1996) 269-276
15. McOmish F., Yap P., Dow B., Follet E.A., Seed C., Keller A.J., et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 32 (1994) 884-892
16. Alter M.J., Kruszon-Moran D., Nainan O.V., McQuillan G.M., Gao F., Moyer L.A., et al. The prevalence of hepatitis C virus infection in the United States, 1998 through 1994. N Engl J Med 341 (1999) 556-562
17. Blatt L.M., Mutchnick M.G., Tong M.J., Klion F.M., Lebovics E., Freilich B., et al. Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. J Viral Hepat 7 (2000) 196-202
18. Mahaney K., Tedeschi V., Maertens G., Di Bisceglie A.M., Vergalla J., Hoofnagle J.H., et al. Genotypic analysis of hepatitis C virus in American patients. Hepatology 20 (1994) 1405-1411
19. Ansaldi F., Bruzzone B., Salmaso S., Rota M.C., Durando P., Gasparini R., et al. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol 76 (2005) 327-332
20. Payan C., Roudot-Thoraval F., Marcellin P., Bled N., Duverlie G., Fouchard-Hubert I., et al. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millennium: the GEMHEP GenoCII Study. J Viral Hepat 12 (2005) 405-413
21. Haushofer A., Kopty C., Hauer R., Brunner H., and Halbmayer W. HCV genotypes and age distribution in patients of Vienna and surrounding areas. J Clin Virol 20 (2001) 41-47
22. Ross R., Viazov S., Renzing-Köhler K., and Roggendorf M. Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis C subtypes. J Med Virol 60 (2000) 122-125
23. Berg T., Hopf U., Stark K., Baumgarten R., Lobeck H., and Schreier E. Distribution of hepatitis C genotypes in German patients with chronic hepatitis C: correlation with clinical and virological parameters. J Hepatol 26 (1997) 484-491
24. García F., Roldán C., García Jr. F., Hernandez J., Garcia-Valdecasas J., Bernal M.C., et al. Subtype distribution among intravenous drug users with chronic type C hepatitis in southern Spain. Microbios 95 (1998) 15-24
25. Pawlotsky J.M., Tsakiris L., Roudot-Thoraval F., Pellet C., Stuyver L., Duval J., et al. Relationship between HCV genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 171 (1995) 1607-1610
26. Cilla G., Garcia-Bengoechea M., Perez-Trallero E., Montalvo I., Vicente D., and Arenas J.I. Genotyping of hepatitis C virus isolates from Basque Country, Spain. Epidemiol Infect 117 (1996) 533-536
27. Dal Molin G., Ansaldi F., Biagi C., D'Agaro P., Comar M., Croce L., et al. Changing molecular epidemiology of hepatitis C virus infection in northeast Italy. J Med Virol 68 (2002) 352-356
28. Herve S., Savoye G., Riachi G., Hellot M.F., Goria O., Lerebours E., et al. Chronic hepatitis C with normal or abnormal aminotransferase levels: is it the same entity?. Eur J Gastroenterol Hepatol 13 (2001) 495-500
29. Fonquernie L., Serfaty L., Charrois A., Wendum D., Lefebvre B., Girard P.M., et al. Significance of hepatitis C virus coinfection with persistently normal ALT levels in HIV-1 infected patients. HIV Med 5 (2004) 385-390
30. Maida I, Soriano V, González-Lahoz J, Núñez M., Liver fibrosis stage in HIV/HCV-coinfected patients with persistently normal transaminase levels [abstract 855]. 45th ICAAC, September 21-24, 2005; New Orleans, Louisiana.
31. Adinolfi L.E., Utili R., Andreana A., Tripodi M.F., Rosario P., Mormone G., et al. Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients. Eur J Gastroenterol Hepatol 12 (2000) 299-304
32. Silini E., Bono F., Cividini A., Cerino A., Bruno S., Rossi S., et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 21 (1995) 285-290
33. Sanchez-Quijano A., Abad M.A., Torronteras R., Rey C., Pineda J.A., Leal M., et al. Unexpected high prevalence of hepatitis C virus genotype 4 in Southern Spain. J Hepatol 27 (1997) 25-29
34. Rosen H., Chou S., Sasaki A., and Gretch D. Molecular epidemiology of hepatitis C infection in U.S. Veteran liver transplant recipients: evidence for decreasing relative prevalence of genotype 1B. Am J Gastroenterol 94 (1999) 3015-3019
35. Seeff L.B., Miller R.N., Rabkin C.S., Buskell-Bales Z., Straley-Eason K.D., Smoak B.L., et al. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 132 (2000) 105-111